MetaCap

Vogenx (VOGX) vs Whitehawk Therapeutics (WHWK)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Whitehawk Therapeutics is the larger company by market cap ($181.2 million vs $176.3 million), about 1.0 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

VOGX-8.69%WHWK-34.82%
+173%+62%-49%
Aug 12, 20261 yearNov 20, 2026
VOGX-19.69%WHWK-31.17%
+138%+47%-43%
Aug 10, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

VOGX versus WHWK key metrics
MetricVOGXWHWK
Share price$11.87$3.07
Market cap$176.33M$181.16M
1-day change-7.30%-1.60%
YTD return—+26.86%
1-year return—+45.50%
5-year return—-86.36%
EPS (TTM)$-0.89$-1.10
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)—$7.14M
Revenue growth (YoY)—-72.50%
Net income (latest FY)—$-20.60M
Gross margin—89.36%
Operating margin—-1601.12%
Net margin—-288.26%
52-week high$38.41$5.50
52-week low$11.51$2.10
Distance from 52-week high-69.10%-44.13%
Analyst consensusstrong_buybuy
Avg. price target upside+363.35%+151.14%
Average volume128.78K348.68K
Shares outstanding14.86M59.01M
Employees437
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About Vogenx

VOGX stock →

Vogenx, Inc. operates as a clinical-stage drug development company that develops therapeutics for metabolic including post-bariatric hypoglycemia, or PBH, and gastroparesis.

Health Care · Biotechnology: Pharmaceutical Preparations · 4 employees

About Whitehawk Therapeutics

WHWK stock →

Whitehawk Therapeutics, Inc., a clinical-stage oncology therapeutics company that develops technologies to establish tumor biology for cancer treatments. It provides three next generation antibody drug conjugates (ADC) portfolio to treat cancer.

Health Care · Biotechnology: Pharmaceutical Preparations · 37 employees

VOGX vs WHWK FAQ

Which is bigger, Vogenx or Whitehawk Therapeutics?

Whitehawk Therapeutics (WHWK) is larger, with a market capitalization of $181.16M compared with $176.33M for Vogenx (VOGX).

Are Vogenx and Whitehawk Therapeutics in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons